Enterome SA of France has formed a three-member scientific advisory board to help guide its work on microbiome-based therapies for cancer. The members are David Klatzmann, professor of immunology at the Sorbonne University in Paris; Pedro Romero, director of scientific and medical affairs at Novigenix, an immuno-transcriptomics company in Switzerland, and Justin Eyquem, an assistant professor of microbiology and immunology at the University of California, San Francisco in the US.
Enterome announced the appointments on 9 May 2023.
Copyright 2023 Evernow Publishing Ltd